Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avid Bioservices announced the appointment of Daniel Hart as chief financial officer.
read more
Patients expect and deserve high-quality drugs – this means consistently safe and effective medicines, free of defects and contamination.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Pfizer announced it will make a $465 million investment to build a sterile injectable pharmaceutical production facility in Portage, Michigan.
read more
West Pharmaceutical Services announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced manufacturing network.
read more
As part of our public health mission, the FDA monitors the pharmaceutical supply chain to support patient access to medically necessary drugs.
read more
MassDevelopment has approved a 2 million dollar loan to Berkshire Sterile Manufacturing (BSM) for expansion of the company's sterile manufacturing facility located in Lee, MA.
read more
Moderna Therapeutics announced the opening of its state-of-the-art manufacturing facility in Norwood, Massachusetts.
read more
ProBioGen AG and Pionyr Immunotherapeutics have announced a second service and license agreement to develop novel antibody therapeutics.
read more
WuXi Biologics and Immune Pharmaceuticals announced a development and manufacturing agreement for the production of bertilimumab, Immune's first-in-class anti-eotaxin-1 monoclonal antibody.
read more
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.
read more
BrainStorm Cell Therapeutics has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute as a second U.S. manufacturing site to supply NurOwn.
read more
TraceLink announced that IBI Lorenzini has selected TraceLink's solutions to ensure compliance with global serialization regulations.
read more
Recipharm and Sanofi announced they have signed an agreement to transfer the Holmes Chapel site from Sanofi to Recipharm.
read more
STA Pharmaceutical announced its partner, Ascletis has received approval from China Food and Drug Administration of its Category 1 new drug, Ganovo, to treat viral hepatitis C.
read more